Southeast Regional Radiation Medical Center "Top Grade in Stomach and Breast Cancer Treatment Evaluation"

[Asia Economy Reporter Kim Bong-su] The Dongnam Institute of Radiological & Medical Sciences (Director Park Sang-il) announced on the 19th that it has been recognized as a hospital excelling in cancer treatment by receiving the highest grade (Grade 1) in the recent adequacy evaluations for stomach cancer and breast cancer conducted by the Health Insurance Review & Assessment Service.

This adequacy evaluation was conducted on hospitalized patients aged 18 and older who were treated for primary cancers (stomach and breast) from January to December 2019 at medical institutions nationwide performing surgeries for stomach cancer (208 institutions) and breast cancer (175 institutions). The evaluation criteria included ▲ the composition of specialized personnel ▲ the implementation of appropriate treatments such as surgery, radiation therapy, and chemotherapy ▲ the completeness of examination and surgery records ▲ average length of hospital stay and inpatient medical expenses. For stomach cancer, a total of 13 indicators were assessed, and for breast cancer, a total of 10 indicators were evaluated.

As a result of the evaluation, the Dongnam Institute of Radiological & Medical Sciences scored a perfect 100 points in the breast cancer adequacy evaluation and 99.46 points in the stomach cancer adequacy evaluation, achieving the highest grade, Grade 1, in both assessments.

In addition to cancer, the institute also received Grade 1 for the sixth consecutive time in the 6th adequacy evaluation for chronic obstructive pulmonary disease (COPD). The Dongnam Institute of Radiological & Medical Sciences is a public institution under the Ministry of Science and ICT.

Park Sang-il, Director of the Dongnam Institute of Radiological & Medical Sciences, stated, "Receiving Grade 1 in the adequacy evaluation announced by the Health Insurance Review & Assessment Service objectively proves excellent patient satisfaction and the level of surgical and treatment management." He added, "We will continue to do our best to provide safe and high-quality medical services not only for cancer but also for general diseases."

This content was produced with the assistance of AI translation services.